Sec Form 13D Filing - Versant Venture Capital VI L.P. filing for TEMPEST THERAPEUTICS INC (TPST) - 2023-11-09

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT

TO RULE 13d-2(a)

(Amendment No. 1)*

 

 

Tempest Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

87978U108

(CUSIP Number)

Versant Venture Capital VI, L.P.

Max Eisenberg

One Sansome Street, Suite 3630

San Francisco, CA 94104

415-801-8100

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

August 10, 2023

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

 

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Venture Capital VI, L.P.

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  WC

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

 

     7.    

  Sole Voting Power

 

  997,940 shares of Common Stock (2)

     8.  

  Shared Voting Power

 

  0

     9.  

  Sole Dispositive Power

 

  997,940 shares of Common Stock (2)

   10.  

  Shared Dispositive Power

 

  0

11.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  997,940 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  7.5% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  PN

 

(1)

This Schedule 13D is filed by Versant Venture Capital IV, L.P. (“Versant IV”), Versant Side Fund IV, L.P. (“Side Fund IV”), Versant Ventures IV, LLC (“LLC IV”), Versant Venture Capital VI, L.P. (“Versant VI”), Versant Ventures VI GP, L.P. (“GP VI”), Versant Ventures VI GP-GP, LLC (“LLC VI”), Versant Vantage II, L.P. (“Vantage II LP”), Versant Vantage II GP, L.P. (“Vantage II GP”), Versant Vantage II GP-GP, LLC (“Vantage II LLC” and, with Versant IV, Side Fund IV, LLC IV, Versant VI, GP VI, LLC VI, Vantage II LP and Vantage II GP, collectively, the “Reporting Persons”). LLC IV is the general partner of Versant IV and Side Fund IV, and LLC IV has voting and dispositive power over the shares held by Versant IV and Side Fund IV. LLC VI is the general partner of GP VI, which is the general partner of Versant VI. Each of LLC VI and GP VI share voting and dispositive power over the shares held by Versant VI. Vantage II LLC is the general partner of Vantage II GP, which is the general partner of Vantage II LP. Each of Vantage II LLC and Vantage II GP share voting and dispositive power over the shares held by Vantage II LP. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

These shares are held by Versant VI. LLC VI is the general partner of GP VI, which is the general partner of Versant VI. Each of LLC VI and GP VI share voting and dispositive power over the shares held by Versant VI and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Issuer’s quarterly report on Form 10-Q for the quarter ended June 30, 2023, filed with the United States Securities and Exchange Commission (the “Commission”) on August 10, 2023 (the “Form 10-Q”).


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Ventures VI GP, L.P.

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  AF

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

 

     7.    

  Sole Voting Power

 

  0

     8.  

  Sh ared Voting Power

 

  997,940 shares of Common Stock (2)

     9.  

  Sole Dispositive Power

 

  0

   10.  

  Shared Dispositive Power

 

  997,940 shares of Common Stock (2)

11.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  997,940 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  7.5% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  PN

 

(1)

This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

These shares are held by Versant VI. LLC VI is the general partner of GP VI, which is the general partner of Versant VI. Each of LLC VI and GP VI share voting and dispositive power over the shares held by Versant VI and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Form 10-Q.


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Ventures VI GP-GP, LLC

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  AF

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

 

     7.    

  Sole Voting Power

 

  0

     8.  

  Shared Voting Power

 

  997,940 shares of Common Stock (2)

     9.  

  Sole Dispositive Power

 

  0

   10.  

  Shared Dispositive Power

 

  997,940 shares of Common Stock (2)

11.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  997,940 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  7.5% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  PN

 

(1)

This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

These shares are held by Versant VI. LLC VI is the general partner of GP VI, which is the general partner of Versant VI. Each of LLC VI and GP VI share voting and dispositive power over the shares held by Versant VI and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Form 10-Q.


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Vantage II, L.P.

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  WC

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

 

     7.    

  Sole Voting Power

 

  2,118,644 shares of Common Stock (2)

     8.  

  Shared Voting Power

 

  0

     9.  

  Sole Dispositive Power

 

  2,118,644 shares of Common Stock (2)

   10.  

  Shared Dispositive Power

 

  0

11.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  2,118,644 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  15.9% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  PN

 

(1)

This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

These shares are held by Vantage II LP. Vantage II LLC is the general partner of Vantage II GP, which is the general partner of Vantage II LP. Each of Vantage II LLC and Vantage II GP share voting and dispositive power over the shares held by Vantage II LP and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Form 10-Q.


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Vantage II GP, L.P.

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  AF

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

 

     7.    

  Sole Voting Power

 

  0

     8.  

  Shared Voting Power

 

  2,118,644 shares of Common Stock (2)

     9.  

  Sole Dispositive Power

 

  0

   10.  

  Shared Dispositive Power

 

  2,118,644 shares of Common Stock (2)

11.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  2,118,644 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  15.9% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  PN

 

(1)

This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

These shares are held by Vantage II LP. Vantage II LLC is the general partner of Vantage II GP, which is the general partner of Vantage II LP. Each of Vantage II LLC and Vantage II GP share voting and dispositive power over the shares held by Vantage II LP and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Form 10-Q.


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Vantage II GP-GP, LLC

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  AF

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

 

     7.    

  Sole Voting Power

 

  0

     8.  

  Shared Voting Power

 

  2,118,644 shares of Common Stock (2)

     9.  

  Sole Dispositive Power

 

  0

   10.  

  Shared Dispositive Power

 

  2,118,644 shares of Common Stock (2)

11.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  2,118,644 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  15.9% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  OO

 

(1)

This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

These shares are held by Vantage II LP. Vantage II LLC is the general partner of Vantage II GP, which is the general partner of Vantage II LP. Each of Vantage II LLC and Vantage II GP share voting and dispositive power over the shares held by Vantage II LP and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Form 10-Q.


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Venture Capital IV, L.P.

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  WC

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

 

     7.    

  Sole Voting Power

 

  1,171,094 shares of Common Stock (2)

     8.  

  Shared Voting Power

 

  0

     9.  

  Sole Dispositive Power

 

  1,171,094 shares of Common Stock (2)

   10.  

  Shared Dispositive Power

 

  0

11.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  1,171,094 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  8.8% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  PN

 

(1)

This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

These shares are held by Versant IV. LLC IV is the general partner of Versant IV and has voting and dispositive power over the shares held by Versant IV and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Form 10-Q.


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Side Fund IV, L.P.

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  WC

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

 

     7.    

  Sole Voting Power

 

  7,377 shares of Common Stock (2)

     8.  

  Shared Voting Power

 

  0

     9.  

  Sole Dispositive Power

 

  7,377 shares of Common Stock (2)

   10.  

  Shared Dispositive Power

 

  0

11.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  7,377 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  0.1% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  PN

 

(1)

This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

These shares are held by Side Fund IV. LLC IV is the general partner of Side Fund IV and has voting and dispositive power over the shares held by Side Fund IV and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Form 10-Q.


CUSIP No. 87978U108    13D

 

  1.    

  Name of Reporting Persons

 

  Versant Ventures IV, LLC

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☐        (b)  ☒(1)

 

  3.  

  SEC Use Only

 

  4.  

  Source of Funds (See Instructions)

 

  AF

  5.  

  Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

  ☐

  6.  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

 

     7.    

  Sole Voting Power

 

  1,178,471 shares of Common Stock (2)

     8.  

  Shared Voting Power

 

  0

     9.  

  Sole Dispositive Power

 

  1,178,471 shares of Common Stock (2)

   10.  

  Shared Dispositive Power

 

  0

11.   &# xA0;

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  1,178,471 shares of Common Stock (2)

12.  

  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  ☐

13.  

  Percent of Class Represented by Amount in Row 11

 

  8.8% (3)

14.  

  Type of Reporting Person (See Instructions)

 

  OO

 

(1)

This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.

(2)

Includes (i) 1,171,094 shares held by Versant IV; and (ii) 7,377 shares held by Side Fund IV. LLC IV is the general partner of Versant IV and Side Fund IV, and LLC IV has voting and dispositive power over the shares held by each of Versant IV and Side Fund IV and as a result may be deemed to have beneficial ownership over such securities.

(3)

Based on 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as set forth in the Form 10-Q.


CUSIP No. 87978U108 13D

 

Explanatory Note:

This Amendment No. 1 (this “Amendment”) amends and supplements the Schedule 13D originally filed by the Reporting Persons with the Commission on May 9, 2022 (the “Original Schedule 13D”). Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13D remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment have the meanings ascribed to them in the Original Schedule 13D.

Item 1. Security and Issuer

The address of the principal executive offices of the Issuer is 2000 Sierra Point Parkway, Suite 400, Brisbane, California, 94005.

Item 2. Identity and Background

(b) The address of the principal offices of each Reporting Person is One Sansome Street, Suite 1650, San Francisco, CA 94104.

Item 4. Purpose of Transaction

Solely on behalf of, and only to the extent that it relates to, the Reporting Persons, Item 4 of the Original Schedule 13D is hereby amended and supplemented by the addition of the following:

The Reporting Persons have previously reserved the right and continue to reserve the right, based on all relevant factors and subject to applicable law or other restrictions, at any time and from time to time, to acquire additional shares of Common Stock or other securities of the Issuer, dispose of some or all of the shares of Common Stock or other securities of the Issuer that it may own from time to time, in each case in open market or private transactions, block sales or otherwise or pursuant to ordinary stock exchange transactions effected through one or more broker-dealers whether individually or utilizing specific pricing or other instructions (including by means of Rule 10b5-1 programs), and review or reconsider their position, change their purpose, take other actions or formulate and implement plans or proposals with respect to any of the foregoing.

The Reporting Persons intend to review their investment in the Issuer from time to time on the basis of various factors, including the Issuer’s business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer’s stock in particular, as well as other developments.

Item 5. Interest in Securities of the Issuer

This information reported below is based on a total of 13,324,065 shares of the Issuer’s Common Stock outstanding as of August 7, 2023, as reported on the Issuer’s Form 10-Q filed with the Commission on August 10, 2023. This Amendment is being filed to update the aggregate percentage of the Issuer’s Common Stock owned by the Reporting Persons due to dilution caused by the Issuer’s sales of additional shares of its Common Stock from time to time since the date of the filing of the Original Schedule 13D. Such transactions resulted in a decrease of over one percent (1%) in the aggregate percentage ownership reported by the Reporting Persons in the Original Schedule 13D.

(a) and (b) See Items 7-11 of the cover pages of this Statement and Item 2 above.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

November 9, 2023

Versant Venture Capital VI, L.P.

By:

 

Versant Ventures VI GP, L.P.

Its:

 

General Partner

By:

 

Versant Ventures VI GP-GP, LLC

Its:

 

General Partner

By:

 

/s/ Max Eisenberg, Chief Operating Officer

Versant Ventures VI GP, L.P.

By:

 

Versant Ventures VI GP-GP, LLC

Its:

 

General Partner

By:

 

/s/ Max Eisenberg, Chief Operating Officer

Versant Ventures VI GP-GP, LLC

By:

 

/s/ Max Eisenberg, Chief Operating Officer

Versant Vantage II, L.P.

By:

 

Versant Vantage II GP, L.P.

Its:

 

General Partner

By:

 

Versant Vantage II GP-GP, LLC

Its:

 

General Partner

By:

 

/s/ Max Eisenberg, Chief Operating Officer

Versant Vantage II GP, L.P.

By:

 

Versant Vantage II GP-GP, LLC

Its:

 

General Partner

By:

 

/s/ Max Eisenberg, Chief Operating Officer

Versant Vantage II GP-GP, LLC

By:

 

/s/ Max Eisenberg, Chief Operating Officer

Versant Venture Capital IV, L.P.

By:

 

Versant Ventures IV, LLC

Its:

 

General Partner

By:

 

/s/ Max Eisenberg, Chief Operating Officer


Versant Venture Capital IV, L.P.

By:

 

Versant Vantage IV, LLC

Its:

 

General Partner

By:

 

/s/ Max Eisenberg, Chief Operating Officer

Versant Side Fund IV, L.P.

By:

 

Versant Ventures IV, LLC

Its:

 

General Partner

By:

 

/s/ Max Eisenberg, Chief Operating Officer

Versant Ventures IV, LLC

By:

 

/s/ Max Eisenberg, Chief Operating Officer